Get startedLog in
    Picture of Arbutus Biopharma logo

    ABUS — Arbutus Biopharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value

    Picture of Arbutus Biopharma logoArbutus Biopharma
    17/05/2024 14:09
    May 17 (Reuters) - Arbutus Biopharma Corp  ABUS.O :
    * WHITEFORT CAPITAL: URGES ARBUTUS BIOPHARMA TO LAUNCH A
STRATEGIC
REVIEW OF ITS HEPATITIS B VIRUS PORTFOLIO BY YEAREND
    * WHITEFORT CAPITAL: OWNS ABOUT 6.8% OF ARBUTUS BIOPHARMA'S
OUTSTANDING SHARES
    * WHITEFORT CAPITAL: CALLS ON ARBUTUS TO CEASE ANY FURTHER
SHARE
ISSUANCES & PLANS TO VOTE AGAINST PROPOSED SHARE INCREASES TO
CO'S INCENTIVE PLAN

Source text for Eikon:  ID:nBwbRDq5Ca 
Further company coverage:  ABUS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Arbutus Biopharma

    See all news